Literature DB >> 27879372

Metabolic Imaging in Parkinson Disease.

Sanne K Meles1, Laura K Teune2, Bauke M de Jong2, Rudi A Dierckx3,4, Klaus L Leenders2.   

Abstract

This review focuses on recent human 18F-FDG PET studies in Parkinson disease. First, an overview is given of the current analytic approaches to metabolic brain imaging data. Next, we discuss how 18F-FDG PET studies have advanced understanding of the relation between distinct brain regions and associated symptoms in Parkinson disease, including cognitive decline. In addition, the value of 18F-FDG PET studies in differential diagnosis, identifying prodromal patients, and the evaluation of treatment effects are reviewed. Finally, anticipated developments in the field are addressed.
© 2017 by the Society of Nuclear Medicine and Molecular Imaging.

Entities:  

Keywords:  FDG-PET; Parkinson’s disease; imaging; metabolism; networks

Mesh：

Substances：

Year:  2016        PMID： 27879372     DOI： 10.2967/jnumed.116.183152

Source DB:  PubMed          Journal:  J Nucl Med        ISSN： 0161-5505            Impact factor:   10.057


  18 in total

Review 1.  Insights into Computational Drug Repurposing for Neurodegenerative Disease.

Authors:  Manish D Paranjpe; Alice Taubes; Marina Sirota
Journal:  Trends Pharmacol Sci       Date:  2019-07-17       Impact factor: 14.819

2.  Functional impact of subthalamotomy by magnetic resonance-guided focused ultrasound in Parkinson's disease: a hybrid PET/MR study of resting-state brain metabolism.

Authors:  Rafael Rodriguez-Rojas; Jose A Pineda-Pardo; Raul Martinez-Fernandez; Rosalie V Kogan; Carlos A Sanchez-Catasus; Marta Del Alamo; Frida Hernández; Lina García-Cañamaque; Klaus L Leenders; Jose A Obeso
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-11-08       Impact factor: 9.236

3.  Role of plasminogen activator inhibitor-1 in the diagnosis and prognosis of patients with Parkinson's disease.

Authors:  Hong Pan; Ying Zhao; Zhengping Zhai; Jinyu Zheng; Yong Zhou; Qijin Zhai; Xiangyang Cao; Jisha Tian; Liandong Zhao
Journal:  Exp Ther Med       Date:  2018-04-17       Impact factor: 2.447

Review 4.  PET Imaging in Movement Disorders.

Authors:  Baijayanta Maiti; Joel S Perlmutter
Journal:  Semin Nucl Med       Date:  2018-08-16       Impact factor: 4.446

Review 5.  Magnetic resonance imaging for the diagnosis of Parkinson's disease.

Authors:  Beatrice Heim; Florian Krismer; Roberto De Marzi; Klaus Seppi
Journal:  J Neural Transm (Vienna)       Date:  2017-04-04       Impact factor: 3.575

6.  Altered microstructural properties of superficial white matter in patients with Parkinson's disease.

Authors:  Yichen Zhang; Biao Huang; Qinyuan Chen; Lijuan Wang; Lu Zhang; Kun Nie; Qinda Huang; Ruiwang Huang
Journal:  Brain Imaging Behav       Date:  2021-08-19       Impact factor: 3.978

Review 7.  The role of neuroimaging in Parkinson's disease.

Authors:  Natasha S R Bidesi; Ida Vang Andersen; Albert D Windhorst; Vladimir Shalgunov; Matthias M Herth
Journal:  J Neurochem       Date:  2021-10-03       Impact factor: 5.546

8.  Neuropathological correlation supports automated image-based differential diagnosis in parkinsonism.

Authors:  Katharina A Schindlbeck; Deepak K Gupta; Chris C Tang; Sarah A O'Shea; Kathleen L Poston; Yoon Young Choi; Vijay Dhawan; Jean-Paul Vonsattel; Stanley Fahn; David Eidelberg
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-04-10       Impact factor: 10.057

9.  Utility of 18F FDG-PET in Parkinsonism in an African population.

Authors:  Ferzana Hassan Amod; Ahmed Iqbal Bhigjee; Nozipho Nyakale
Journal:  eNeurologicalSci       Date:  2022-03-31

Review 10.  Glucose metabolic crosstalk and regulation in brain function and diseases.

Authors:  Shuai Zhang; Brittany Bolduc Lachance; Mark P Mattson; Xiaofeng Jia
Journal:  Prog Neurobiol       Date:  2021-06-10       Impact factor: 10.885
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.